ARCHIVES

House committee asks GAO to investigate Klausner-era NCI contract with Harvard University.

This article is from The Cancer Letter archive.

Vol. 31 No. 32 | September 9, 2005

Download PDF Visit The Full Archive

Related Articles

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011